Enzychem Lifesciences Corporation (183490.KQ) KOE

1,137.00

+17(+1.52%)

Updated at February 20 03:30PM

Currency In KRW

Valuation

Market Cap130.15B
Enterprise Value130.15B
P/E Ratio-6.96
PEG Ratio-0.16
Price/Sales Ratio1.29
Price/Book Ratio0.65
Enterprise/Revenue1.2
Enterprise/EBITDA-11.7

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.21
Operating Margin-0.21

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.09

Income Statement

Revenue67.75B
Revenue/Share796.45
Gross Profit0
EBITDA-14.25B
Net Income-13.82B
Diluted EPS-162.43

Balance Sheet

Total Cash110.3B
Total Cash/Share1,257.51
Total Debt4.14B
Total Debt/Equity0.03
Current Ratio17.56
Book Value Per Share1,768.26

Price History

52-Week Change-13.73
52-Week High1,766
52-Week Low937
Moving Average 50 Days1,314.78
Moving Average 200 Days1,157.04

Statistics

Average Volume776,570
Shares Outstanding77.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor6:1
Last Split DateAugust 17, 2022